GGrantIndex
← Leaderboards

Sami Barmada

University Of Michigan At Ann Arbor

$8,649,535
Attributed
$8,846,048
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201125
$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,846,048 · 5

By mechanism

R01$5,779,927 · 2
R37$1,794,354 · 1
K08$878,740 · 1
R56$393,027 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsRna-Binding ProteinsNeuronsNerve DegenerationAffectPathologicAmyotrophic Lateral SclerosisPathogenesisNeuron LossDepositionPreventProtein Tdp-43ProteinsPathologyToxic EffectMutationMediatingHomeostasisCellsLabelMutantNeurodegenerative DisordersBindingFrontotemporal Lobar Degenerations

Grant awards (23)

Regulation and impact of shortened TDP43 isoforms in FTD and ALS$1,794,354
R37 · FY2025 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$385,108
R01 · FY2025 · NS · contact PI
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS$390,000
R01 · FY2024 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$373,555
R01 · FY2024 · NS · contact PI
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS$390,000
R01 · FY2023 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$385,108
R01 · FY2023 · NS · contact PI
Spatiotemporal analysis of TDP-43 toxicity and endolysosomal turnover mechanisms$393,027
R56 · FY2022 · NS
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS$390,000
R01 · FY2022 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$385,108
R01 · FY2022 · NS · contact PI
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS$390,000
R01 · FY2021 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$371,948
R01 · FY2021 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$387,500
R01 · FY2020 · NS · contact PI
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS$381,600
R01 · FY2020 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$387,500
R01 · FY2019 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$387,500
R01 · FY2018 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$387,500
R01 · FY2017 · NS · contact PI
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration$387,500
R01 · FY2016 · NS · contact PI
Elucidating the Mechanisms Underlying Mutant TDP43-induced Neurodegeneration$176,948
K08 · FY2015 · NS · contact PI
Elucidating the Mechanisms Underlying Mutant TDP43-induced Neurodegeneration$175,448
K08 · FY2014 · NS · contact PI
Elucidating the Mechanisms Underlying Mutant TDP43-induced Neurodegeneration$169,441
K08 · FY2013 · NS · contact PI
Elucidating the Mechanisms Underlying Mutant TDP43-induced Neurodegeneration$6,007
K08 · FY2013 · NS · contact PI
Elucidating the Mechanisms Underlying Mutant TDP43-induced Neurodegeneration$175,448
K08 · FY2012 · NS · contact PI
Elucidating the Mechanisms Underlying Mutant TDP43-induced Neurodegeneration$175,448
K08 · FY2011 · NS · contact PI